| IRGTX | MGLRX | IRGTX / MGLRX | |
| Total Expense Ratio | 1.15 | 0.85 | 135% |
| Annual Report Gross Expense Ratio | 1.31 | 0.86 | 152% |
| Fund Existence | 20 years | 13 years | - |
| Gain YTD | 6.906 | 0.746 | 925% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 133M | 2.21B | 6% |
| Annual Yield % from dividends | 2.67 | 2.55 | 105% |
| Returns for 1 year | 6.27 | 0.06 | 10,144% |
| Returns for 3 years | 19.40 | 9.18 | 211% |
| Returns for 5 years | 14.28 | -1.53 | -933% |
| Returns for 10 years | 20.28 | 33.20 | 61% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RAPZX | 11.13 | 0.05 | +0.45% |
| Cohen & Steers Real Assets Z | |||
| BRWCX | 26.02 | N/A | N/A |
| MFS Blended Research Growth Eq C | |||
| JAGLX | 81.02 | -0.20 | -0.25% |
| Janus Henderson Global Life Sciences T | |||
| VSFSX | 25.51 | -0.07 | -0.27% |
| Federated Hermes MDT Small Cap Value R6 | |||
| PHPIX | 36.09 | -0.16 | -0.44% |
| ProFunds Pharmaceuticals UltraSector Inv | |||